在小鼠中,NR2F6调节干细胞血液形成和骨髓形成
Johannes Woelk1, Hamsa Narasimhan2,3, Christa Pfeifhofer-Obermair4
1Institute of Cell Genetics, Department for Genetics and Pharmacology, Medical University of Innsbruck, Innsbruck, Austria.
Frontiers in immunology
|January 22, 2025
概括
核孤儿受体NR2F6调节造血干细胞 (HSC) 和免疫细胞的发育. 在小鼠中,NR2F6的损失增加了HSCs,但减少了某些骨髓原始体,影响了骨髓血液形成.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 核受体,包括NR2F6 (EAR-2),在调节造血干细胞 (HSC) 和免疫细胞方面发挥作用.
- 以前的研究表明NR2F6影响小鼠血液形成,但功能丧失模型中对祖先种群的详细分析缺乏.
研究的目的:
- 通过遗传功能丧失模型,研究NR2F6在骨髓中调节不同干细胞,髓状细胞和淋巴状细胞原始细胞种群中的作用.
- 分析NR2F6缺乏对血液形成和骨髓形成的影响.
主要方法:
- 利用生殖系Nr2f6缺陷的小鼠进行遗传功能丧失研究.
- 在骨髓中分析了HSC,多能原始体 (MPP),常见髓状原始体 (CMP),粒细胞-单细胞原始体 (GMP),单细胞-树突原始体 (MDP) 和常规前树突原始体 (pre-cDC) 的百分比.
主要成果:
- 成人Nr2f6缺乏的小鼠显示长期和短期HSC和MPP3细胞的百分比增加.
- 损失NR2F6导致GMPs下降,MDPs增加.
- 在Nr2f6缺乏的小鼠中观察到前cDC2s的减少,在常见的淋巴原体发育中没有显著差异.
结论:
- NR2F6在调节小鼠骨髓中HSC百分比和骨髓原体分化方面发挥着关键作用.
- 这些发现突出了NR2F6在血液形成和骨髓形成期间控制基因表达的参与,与之前的一些研究形成鲜明对比.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Hematopoiesis
5.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.1K
Role of Hematopoietic Growth Factors
1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.2K
Overview of Hematopoiesis
3.7K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
3.7K


